84 related articles for article (PubMed ID: 22610389)
1. Thallium-201 scintigraphy for the assessment of long-term prognosis in patients with osteosarcoma.
Inaki A; Taki J; Wakabayashi H; Sumiya H; Zen Y; Tsuchiya H; Kinuya S
Ann Nucl Med; 2012 Aug; 26(7):545-50. PubMed ID: 22610389
[TBL] [Abstract][Full Text] [Related]
2. Noninvasive imaging with thallium-201 scintigraphy may not correlate with survival in patients with osteosarcoma.
Magnan H; Chou AJ; Chou JF; Yeung HW; Healey JH; Meyers PA
Cancer; 2010 Sep; 116(17):4147-51. PubMed ID: 20564163
[TBL] [Abstract][Full Text] [Related]
3. [Value of thallium-201 scintigraphy in assessment of neoadjuvant chemotherapy for osteosarcoma].
Huang ZK; Lou C; Fang XQ
Zhonghua Zhong Liu Za Zhi; 2009 Oct; 31(10):769-72. PubMed ID: 20021831
[TBL] [Abstract][Full Text] [Related]
4. Midcourse thallium-201 scintigraphy to predict tumor response in bone and soft-tissue tumors.
Sumiya H; Taki J; Tsuchiya H; Nonomura A; Miyauchi T; Tonami N
J Nucl Med; 1998 Sep; 39(9):1600-4. PubMed ID: 9744351
[TBL] [Abstract][Full Text] [Related]
5. Assessment of chemosensitivity in patients with malignant bone and soft tissue tumors using thallium-201 scintigraphy and doxorubicin binding assay.
Murata H; Kusuzaki K; Takeshita H; Hirata M; Hashiguchi S; Emoto K; Ashihara T; Hirasawa Y
Anticancer Res; 2000; 20(5C):3967-70. PubMed ID: 11268485
[TBL] [Abstract][Full Text] [Related]
6. Quantitative (201)thallium scintigraphy for prediction of histological response to neoadjuvant chemotherapy in osteosarcoma; systematic review and meta-analysis.
Kubo T; Shimose S; Fujimori J; Furuta T; Ochi M
Surg Oncol; 2015 Sep; 24(3):194-9. PubMed ID: 26092710
[TBL] [Abstract][Full Text] [Related]
7. [²⁰¹TI and (99m)Tc-MIBI scintigraphy in evaluation of neoadjuvant chemotherapy for osteosarcoma].
Huang ZK; Lou C; Shi GH
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2012 Mar; 41(2):183-7, 191. PubMed ID: 22499516
[TBL] [Abstract][Full Text] [Related]
8. Thallium-201 scintigraphy for the evaluation of tumor response to preoperative chemotherapy in patients with osteosarcoma.
Imbriaco M; Yeh SD; Yeung H; Zhang JJ; Healey JH; Meyers P; Huvos AG; Larson SM
Cancer; 1997 Oct; 80(8):1507-12. PubMed ID: 9338476
[TBL] [Abstract][Full Text] [Related]
9. Quantitative thallium-201 scintigraphy in childhood osteosarcoma: Comparison with technetuim-99m MDP and magnetic resonance imaging in the evaluation of chemotherapeutic response.
Ilhan IE; Vural G; Berberoglu S; Kapucuoglu N; Cila A; Eke S
Pediatr Hematol Oncol; 2005 Mar; 22(2):153-62. PubMed ID: 15805001
[TBL] [Abstract][Full Text] [Related]
10. Imaging assessment of the responses of osteosarcoma patients to preoperative chemotherapy: angiography compared with thallium-201 scintigraphy.
Kunisada T; Ozaki T; Kawai A; Sugihara S; Taguchi K; Inoue H
Cancer; 1999 Sep; 86(6):949-56. PubMed ID: 10491520
[TBL] [Abstract][Full Text] [Related]
11. The correlation of Tc-99m MIBI scintigraphy and histological response in determining the percentage of tumor necrosis in osteosarcoma after preoperative chemotherapy.
Punyaratabandhu T; Wittayawongsaruji S; Rajchadara S; Thanakit V; Charoenvareekul S; Khunkitti N; Songpatanasilp T
J Med Assoc Thai; 2005 Nov; 88 Suppl 3():S53-62. PubMed ID: 16862675
[TBL] [Abstract][Full Text] [Related]
12. Serial thallium-201 scintigraphy in osteosarcoma. Correlation with tumor necrosis after preoperative chemotherapy.
Rosen G; Loren GJ; Brien EW; Ramana L; Waxman A; Lowenbraun S; Eckardt JJ; Eilber F; Menendez L; Mirra JM
Clin Orthop Relat Res; 1993 Aug; (293):302-6. PubMed ID: 8393392
[TBL] [Abstract][Full Text] [Related]
13. Thallium-201 scintigraphy to assess effect of chemotherapy in osteosarcoma.
Ohtomo K; Terui S; Yokoyama R; Abe H; Terauchi T; Maeda G; Beppu Y; Fukuma H
J Nucl Med; 1996 Sep; 37(9):1444-8. PubMed ID: 8790189
[TBL] [Abstract][Full Text] [Related]
14. A reassessment of bone scintigraphy and commonly tested pretreatment biochemical parameters in newly diagnosed osteosarcoma.
Stokkel MP; Linthorst MF; Borm JJ; Taminiau AH; Pauwels EK
J Cancer Res Clin Oncol; 2002 Jul; 128(7):393-9. PubMed ID: 12136254
[TBL] [Abstract][Full Text] [Related]
15. Effect of increases in tumor volume after neoadjuvant chemotherapy on the outcome of stage II osteosarcoma regardless of histological response.
Kim MS; Lee SY; Cho WH; Song WS; Koh JS; Lee JA; Yoo JY; Jung ST; Jeon DG
J Orthop Sci; 2009 May; 14(3):292-7. PubMed ID: 19499296
[TBL] [Abstract][Full Text] [Related]
16. Relative tumor burden predicts metastasis-free survival in pediatric osteosarcoma.
Lee JA; Kim MS; Kim DH; Lim JS; Yoo JY; Koh JS; Lee SY; Jeon DG; Park KD
Pediatr Blood Cancer; 2008 Feb; 50(2):195-200. PubMed ID: 18061933
[TBL] [Abstract][Full Text] [Related]
17. Intense 201 Tl uptake in giant-cell tumour of bone.
Higuchi T; Taki J; Sumiya H; Kinuya S; Bunko H; Nonomura A; Tsuchiya H; Tonami N
Nucl Med Commun; 2002 Jun; 23(6):595-9. PubMed ID: 12029217
[TBL] [Abstract][Full Text] [Related]
18. Thallium-201 Uptake of Giant Cell Tumor: One Step Toward the Differential Diagnosis to Atypically Presenting Osteosarcoma.
Keller S; Inai R; Sato S; Tada A; Adam G; Yamamura J; Kanazawa S
AJR Am J Roentgenol; 2017 Jan; 208(1):171-179. PubMed ID: 27726429
[TBL] [Abstract][Full Text] [Related]
19. Prognostic value of Tc-99m-MIBI performed during middle course of preoperative chemotherapy in patients with malignant bone and soft-tissue tumors.
Wakabayashi H; Taki J; Inaki A; Sumiya H; Zen Y; Tsuchiya H; Kinuya S
Clin Nucl Med; 2012 Jan; 37(1):1-8. PubMed ID: 22157020
[TBL] [Abstract][Full Text] [Related]
20. Initial metabolic tumor volume measured by 18F-FDG PET/CT can predict the outcome of osteosarcoma of the extremities.
Byun BH; Kong CB; Park J; Seo Y; Lim I; Choi CW; Cho WH; Jeon DG; Koh JS; Lee SY; Lim SM
J Nucl Med; 2013 Oct; 54(10):1725-32. PubMed ID: 23949909
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]